Pfizer Strategic Management

678 Words3 Pages
Strategic Management This section investigates the internal and external factors that affect the management strategy of Pfizer. PESTE Analysis This analysis takes a look at external factors effecting Pfizer Political Economic - In recent years economic downturn has created a more competitive market for pfizer as they are losing customers to generic brands. - Many householders are reducing their visits to their local GP and hence forgoing pharmaceutical treatment. Social - Technological - Continuous technological developments make it possible for Pfizer to develop new products and aid research and development teams to sped up the process of bringing new drugs to market. Breaking into the market before competitors is of crucial importance. This means that Pfizer need to constantly update their technological awareness to retain their position as market leaders. Demographic - In recent history humans have drastically lengthened their expected life span. Generations of elderly are living longer than before. This trend is expected to continue. Though people are experiencing health complications as they approach ‘old-age’ they are living longer with them for longer. This is increasing the demand for certain pharmaceutical’s. Value Chain Analysis SWOT Analysis Strengths • Pfizer are industry leaders in the area of Pharmaceuticals and Biotech • Strong sales and marketing infrastructure • Strong R&D departments with a broad therapeutic coverage • Marketing strength in major geographical and therapeutic areas • Existing Patent protection for a number of years on key products • Strong brands such as Viagra, Celebrex, Norvasc, and Lipitor. • Pfizer own a number of Blockbuster Drugs including the most lucrative drug of 2012 Atorvastatin and Etanercept. In late 2012 Pfizer gained FDA approval for Eliquis, a blood thinner, one of the

More about Pfizer Strategic Management

Open Document